[1] |
Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019[J]. N Engl J Med, 2020, 382(8):727-733.
|
[2] |
Hallan S, Matsushita K, Sang Y, et al. Age and association of kidney measures with mortality and end-stage renal disease[J]. JAMA, 2012, 308(22):2349-2360.
|
[3] |
国家统计局.中华人民共和国2018年国民经济和社会发展统计公报[EB/OL].(2019-02-28)[2020-02-23].
URL
|
[4] |
Schmitt R, Melk A. Molecular mechanisms of renal aging[J]. Kidney Int, 2017, 92(3):569-579.
|
[5] |
Ji X, Ji S, He X, et al. Influences of renal function descriptors on population pharmacokinetic modeling of vancomycin in Chinese adult patients[J]. Acta Pharmacol Sin, 2018, 39(2):286-293.
|
[6] |
Blot S, Lipman J, Roberts DM, et al. The influence of acute kidney injury on antimicrobial dosing in critically ill patients: are dose reductions always necessary[J]. Diagn Microbiol Infect Dis, 2014, 79(1):77-84.
|
[7] |
Hoffmann M, Kleine-Weber H, Krüger N, et al. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells [J/OL]. BioRxiv, 2020, doi: 10.1101/2020.01.31.929042.
|
[8] |
|
[9] |
郝文科,吴燕华.老年慢性肾脏疾病患者新型冠状病毒肺炎的防治建议[EB/OL].(2019-02-12)[2020-02-23].
URL
|
[10] |
国家卫生健康委办公厅,国家中医药管理局办公室.关于印发新型冠状病毒肺炎诊疗方案(试行第六版)的通知[EB/OL].(2020-02-19)[2020-02-23].
URL
|
[11] |
Zhou P, Yang X, Wang X, et al. Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin[J/OL]. BioRxiv, 2020, doi: 10.1101/2020.01.22.914952.
|
[12] |
Zhao Y, Zhao Z, Wang Y, et al. Singke-cell RNA expression profiling of ACE2,the putative receptor of Wuhan 2019-nCov[J/OL]. BioRxiv, 2020, doi: 10.1101/2020.01.26.919985.
|
[13] |
刘力生,孙宏涛.新型冠状病毒肺炎患者的高血压药物调整[EB/OL].(2020-02-09)[2020-02-23].
URL
|
[14] |
区文超.高血压患者防疫期须知这三个问题.广州日报,2020.
URL
|
[15] |
李勇,李玉明.新型冠状病毒感染与ACE2相关,ACEI或ARB潜在价值几何[EB/OL]?2020(2020-02-16)[2020-02-23].
URL
|
[16] |
|